These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23871851)

  • 1. In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.
    Aref M; Gallant MA; Organ JM; Wallace JM; Newman CL; Burr DB; Brown DM; Allen MR
    Bone; 2013 Oct; 56(2):449-53. PubMed ID: 23871851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
    PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference point indentation is insufficient for detecting alterations in traditional mechanical properties of bone under common experimental conditions.
    Krege JB; Aref MW; McNerny E; Wallace JM; Organ JM; Allen MR
    Bone; 2016 Jun; 87():97-101. PubMed ID: 27072518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs.
    Allen MR; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Newman CL; Burr DB; Hutchins GD
    J Bone Miner Res; 2015 Aug; 30(8):1441-4. PubMed ID: 25644867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene enhances vertebral mechanical properties independent of bone density.
    Allen MR; Iwata K; Sato M; Burr DB
    Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
    Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
    Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo reference point indentation measurement variability in skeletally mature inbred mice.
    Srisuwananukorn A; Allen MR; Brown DM; Wallace JM; Organ JM
    Bonekey Rep; 2015; 4():712. PubMed ID: 26131362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
    Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
    Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG; Wallace JM; Bart ZR; Allen MR
    Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.
    Allen MR; Hogan HA; Hobbs WA; Koivuniemi AS; Koivuniemi MC; Burr DB
    Endocrinology; 2007 Aug; 148(8):3908-13. PubMed ID: 17478550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
    Newman CL; Creecy A; Granke M; Nyman JS; Tian N; Hammond MA; Wallace JM; Brown DM; Chen N; Moe SM; Allen MR
    Kidney Int; 2016 Jan; 89(1):95-104. PubMed ID: 26489025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
    Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
    Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment.
    Burket JC; Brooks DJ; MacLeay JM; Baker SP; Boskey AL; van der Meulen MC
    Bone; 2013 Jan; 52(1):326-36. PubMed ID: 23092698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of in vivo reference point indentation in skeletally mature inbred rats.
    Allen MR; Newman CL; Smith E; Brown DM; Organ JM
    J Biomech; 2014 Jul; 47(10):2504-7. PubMed ID: 24856912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.
    Allen MR; Reinwald S; Burr DB
    Calcif Tissue Int; 2008 May; 82(5):354-60. PubMed ID: 18463913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
    Allen MR; Kubek DJ; Burr DB
    J Bone Miner Res; 2010 Jan; 25(1):98-105. PubMed ID: 19580463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing.
    Gallant MA; Brown DM; Organ JM; Allen MR; Burr DB
    Bone; 2013 Mar; 53(1):301-5. PubMed ID: 23274349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into reference point indentation involving human cortical bone: sensitivity to tissue anisotropy and mechanical behavior.
    Granke M; Coulmier A; Uppuganti S; Gaddy JA; Does MD; Nyman JS
    J Mech Behav Biomed Mater; 2014 Sep; 37():174-85. PubMed ID: 24929851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
    Allen MR; Burr DB
    J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.